Can iron disorders be missed when screening relies on ferritin or serum iron alone?

Clinical evidence

• Single-marker screening failures: Conventional screening protocols that rely solely on serum ferritin or serum iron miss a substantial portion of patients with iron dysregulation. For instance, using serum ferritin alone (at a threshold of >300 µg/L) has a clinical sensitivity of only approximately 50% for detecting C282Y homozygotes.
• Biomarker discordance: Transferrin saturation (TSAT) typically becomes abnormal and elevated long before significant ferritin elevations manifest. This leads to early-stage discordant profiles (elevated TSAT with normal ferritin) that are entirely missed when screening does not measure both markers concurrently.
• Guideline recommendations: To avoid missed diagnoses, major clinical guidelines—including the American College of Gastroenterology (ACG) and the European Association for the Study of the Liver (EASL)—unanimously advocate for concurrent screening of both TSAT and serum ferritin.

Mechanistic explanations

• Genetic modifiers: Variants in the HFE gene (such as C282Y and H63D) impair systemic iron sensing, leading to relative hepcidin deficiency and increased iron absorption. In mild or heterozygous states, this presents as elevated TSAT while ferritin remains normal.
• Inflammatory signaling: Inflammatory cytokines like IL-6 activate hepatic JAK/STAT signaling to strongly induce hepcidin expression.
• Ferroportin degradation: Elevated hepcidin binds to and degrades the iron exporter ferroportin, trapping iron inside macrophages and enterocytes. This reticuloendothelial blockade produces a classic discordant pattern: low TSAT (representing functional iron deficiency) paired with elevated ferritin (acting as an acute-phase reactant).

Bottom line

Diagnostic screening focusing on ferritin or serum iron alone misses approximately half of early-stage iron dysregulation cases. Accurate clinical assessment requires evaluating both transferrin saturation and serum ferritin concurrently to capture the discordant biomarker patterns produced by the interplay of genetic absorption, inflammatory hepcidin signaling, and metabolic factors.